FDA OKs Edwards Lifesciences System

Irvine-based Edwards Lifesciences Corp., which makes products to treat heart disease, said it received approval from the Food and Drug Administration to sell its Thrombex PMT System, which removes blood clots from grafted blood vessels.

The stock closed at $18.63, up 13 cents a share, on the New York Stock Exchange.